Reducing the Impact of Rheumatic Heart Disease across the Life Span: The Impact Program
减少风湿性心脏病对整个生命周期的影响:影响计划
基本信息
- 批准号:10594560
- 负责人:
- 金额:$ 24.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2027-02-28
- 项目状态:未结题
- 来源:
- 关键词:AddressAdvisory CommitteesAfrica South of the SaharaAfricanCaringChildClinical TrialsCollaborationsCountryDegree programDiseaseDoctor of PhilosophyE-learningEarly DiagnosisEducational workshopEnsureFellowshipFundingGenderGenerationsGoalsGrantGuidelinesHealthHeartHospitalsIncomeInstitutionKnowledgeLongevityMedical centerMedicineMentorsPediatric HospitalsPersonsPoliciesResearchResearch ActivityResearch PersonnelResearch TrainingResourcesRheumatic Heart DiseaseTrainingTraining ActivityTraining ProgramsTraining SupportTranslatingUgandaUnited States National Institutes of HealthUniversitiesVisionWomanburden of illnesscareer developmentexperienceheart disease preventionimprovedinnovationlow and middle-income countriesmedical schoolsnext generationparityprofessorprogramsrecruitsexsuccesswebinar
项目摘要
This application seeks funding for a D43 training grant to support a world-first rheumatic heart disease
(RHD) research training program in Uganda. There has been little innovation globally in RHD prevention,
early detection, and management since the mid-1900’s. Additionally, the majority of evidence guiding
current practice was generated in high-income countries and may not translate directly to the contemporary
burden of disease in low- and middle-income countries (LMICs). The Impact Mentored Research-Training
Program will leverage existing resources and ongoing RHD clinical trials from a decade-long RHD research
and training collaboration between Makerere University, the Uganda Heart Institute (UHI), Cincinnati
Children’s Hospital Medical Centre (CCHMC) and Children’s National Hospital (CNH) to build capacity to
tackle RHD where the burden is the highest. Our overarching objective is to equip and nurture emerging
research leaders and professional scholars in Uganda to generate high-quality contemporary evidence on
RHD across the lifespan and to create an enduring research training center on the African continent that
will rapidly advance progress towards the elimination of the disease in a generation; a bold, but achievable
goal. This application will provide critical support for the training, and research activities needed to realize
this vision. The program will be led by Dr. Nelson Sewankambo, a Professor of Medicine
and Former Dean of the Makerere University School of medicine, who has led several NIH and non-NIH
research capacity building grants in Uganda and sub-Saharan Africa. Co-directing this program are the co-
Directors of the Rheumatic Heart Disease Research Collaborative in Uganda (RRCU), Drs. Emmy Okello
(UHI) and Andrea Beaton (CCHMC). Long-term degree training at Master’s, PhD and Career development
fellowship levels will be offered, with primary coursework to occur in Uganda at MakCHS. CNH will provide
both e-learning seminar and in-person immersive experience in the US to strengthen clinical trials capacity
and improve trainee’s knowledge of gender parity and sex- and gender considerations in health research.
Additionally, recruitment will target trainees from the regional centers to build National RHD capacity and
ensure at least 50% of our trainees are women. Short-term trainings, seminars, webinars and workshops
will be offered to degree and non-degree trainees to further strengthen institutional and national RHD-
research capacity and to identify promising candidates for degree programs. A Steering Committee and
the Training Advisory Committee (TAC) comprised of leading researchers with expertise in our objectives
will both offer expert advice to the Impact Directors to ensure success of the trainees and the overall
program by producing high-quality and locally relevant research. This success will translate into improving
guidelines and policies for RHD care in Uganda and the region, training the next generation of excellent
African researchers to address RHD prevention, early detection, and management.
本申请寻求资助D43培训补助金,以支持世界上第一个风湿性心脏病
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrea Zawacki Beaton其他文献
Andrea Zawacki Beaton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrea Zawacki Beaton', 18)}}的其他基金
Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE)
肌肉注射与肠内青霉素预防预防潜在风湿性心脏病进展:一项非劣效性随机试验。
- 批准号:
10571212 - 财政年份:2023
- 资助金额:
$ 24.24万 - 项目类别:
Reducing the Impact of Rheumatic Heart Disease across the Life Span: The Impact Program
减少风湿性心脏病对整个生命周期的影响:影响计划
- 批准号:
10469186 - 财政年份:2022
- 资助金额:
$ 24.24万 - 项目类别:
Accelerating Delivery of rheumatic heart disease preventive iNterventions in Uganda (ADUNU)
乌干达加速实施风湿性心脏病预防干预措施 (ADUNU)
- 批准号:
10500950 - 财政年份:2022
- 资助金额:
$ 24.24万 - 项目类别:
相似海外基金
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
- 批准号:
0451289 - 财政年份:2005
- 资助金额:
$ 24.24万 - 项目类别:
Standard Grant














{{item.name}}会员




